Skip to content

Clinical trials

Phase 2 Neoplasms, Glandular and Epithelial trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms, Glandular and Epithelial Phase: Phase 2 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20111
20221
20233
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Not yet recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Boston Scientific Corporation1
Cedars-Sinai Medical Center1
Dendreon1
Heath Skinner1
Neovii Biotech1
NiKang Therapeutics, Inc.1
VA Office of Research and Development1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms, Glandular and Epithelial10
Carcinoma8
Adenocarcinoma7
Neoplasms7
Neoplasms by Histologic Type5
Neoplasms by Site3
Pathologic Processes3
Prostatic Neoplasms3
Urogenital Neoplasms3
DNA Virus Infections2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.